公开(公告)号：KR101058794B1

公开(公告)日：2011-08-23

申请号：KR1020090034352

申请日：2009-04-20

Applicant: 전남대학교산학협력단

Inventor： 지연태 ,  최윤희 ,  남지영

IPC: C12N1/20 ,  A01N63/02 ,  C12R1/385 ,  A61K35/74

CPC classification number: Y02A50/473

Abstract: 본 발명은 궤양병에 대한 항생물질을 생산하는 신규한 슈도모나스 에루기노사 NO3 균주, 이의 돌연변이주 및 이들을 이용한 궤양병 치료용 항생물질의 생산방법에 관한 것으로서 보다 상세하게는 궤양병에 대한 항생물질을 생산하는 신규한 슈도모나스 에루기노사 NO3(Pseudomonas aeruginosa NO3)(KFCC 11444P) 균주, 슈도모나스 에루기노사 NO3 균주의 돌연변이주로서 궤양병에 대한 항생물질을 생산하며, 슈도모나스 에루기노사 NO3(Pseudomonas aeruginosa NO3)(KFCC 11444P) 균주에 miniTn5::tet 트랜스포손(transposon)을 접합시켜 얻은 슈도모나스 에루기노사 NO3-291(Pseudomonas aeruginosa NO3-291)(KFCC 11445P) 균주; 슈도모나스 에루기노사 NO3(Pseudomonas aeruginosa NO3)(KFCC 11444P) 및/또는 슈도모나스 에루기노사 NO3-291(Pseudomonas aeruginosa NO3-291)(KFCC 11445P)를 이용한 궤양병 치료용 항생물질의 생산방법에 관한 것이다.
슈도모나스 에루기노사, 천연항생제, 감귤궤양병, 그람 양성균, 항생제내성

公开(公告)号：KR1020100115659A

公开(公告)日：2010-10-28

申请号：KR1020090034352

申请日：2009-04-20

Applicant: 전남대학교산학협력단

Inventor： 지연태 ,  최윤희 ,  남지영

IPC: C12N1/20 ,  A01N63/02 ,  C12R1/385 ,  A61K35/74

CPC classification number: Y02A50/473 ,  C12N1/20 ,  A01N63/02 ,  A61K35/74 ,  C12R1/385

Abstract: PURPOSE: A novel Pseudomonas aeruginosa NO3 strain which produces antibiotics to bacterial canker and mutant thereof are provided to bacterial canker. CONSTITUTION: A novel Pseudomonas aeruginosa NO3(KFCC 11444P) produces antibiotics material to bacterial canker. The bacterial canker is Xanthomonas citri or Pseudomonas syringae pv actinidiae. The antibiotics contain linollenic acid. The Pseudomonas aeruginosa is obtained by hybridizing miniTn5::tet transposon.

Abstract translation: 目的：为细菌溃疡提供一种新的绿色荧光假单胞菌NO3菌株，其对细菌溃疡及其突变体产生抗生素。 构成：一种新型绿脓假单胞菌NO3（KFCC 11444P）生产抗菌素至细菌溃疡。 细菌溃疡是黄单胞菌属黄单胞菌（Pseudomonas syringae pv actinidiae）。 抗生素含有亚麻酸。 通过杂交miniTn5 :: tet转座子获得铜绿假单胞菌。

公开(公告)号：KR1020070109124A

公开(公告)日：2007-11-15

申请号：KR1020060041650

申请日：2006-05-09

Applicant: 전남대학교산학협력단 ,  에이엠팜(주)

Inventor： 지연태 ,  류재원 ,  장치호

IPC: C12N1/20

Abstract: A novel Bacillus sp. CMB32 is provided to be used for producing an antibacterial material from a culture material thereof. And a controlling agent of plant pathogenic bacteria comprising the same is provided to be used as an insecticide for preventing and treating injurious insects and mold. A Bacillus sp. CMB32 which is antagonistic strain of plant pathogens is deposited as a deposition no. KCTC 10940BP. An antibiotic material such as iturin A, fengycin and surfactin A is produced from a culture material obtained by culturing the Bacillus sp. CMB32. A controlling agent of plant pathogenic bacteria comprises the Bacillus sp. CMB32 or a culture solution thereof.

Abstract translation: 一种新型芽孢杆菌 CMB32用于从其培养材料制备抗菌材料。 提供包含该植物病原体的植物病原菌的控制剂用作防止和治疗有害昆虫和霉菌的杀虫剂。 芽孢杆菌 作为植物病原体的拮抗菌株的CMB32沉积为沉积物。 KCTC 10940BP。 通过培养芽孢杆菌属（Bacillus sp。）获得的培养材料产生诸如神经蛋白A，风霉素和表面活性素A的抗生素材料。 CMB32。 植物病原菌的控制剂包括芽孢杆菌属 CMB32或其培养液。

公开(公告)号：KR100763007B1

公开(公告)日：2007-10-04

申请号：KR1020060041651

申请日：2006-05-09

Applicant: 전남대학교산학협력단 ,  에이엠팜(주)

Inventor： 지연태 ,  류진아 ,  이지연 ,  류재원 ,  장치호

IPC: A61K31/202 ,  A61P31/00

Abstract: Antibiotics comprising eicosapentaenoic acid as an active ingredient are provided to inhibit growth of gram positive pathogenic bacteria and antibiotic-resistant strains commonly occurring in human and animals, and produce a large quantity of eicosapentaenoic acid by treating eicosapentaenoic acid derivatives obtained from the strain with a protein-decomposing enzyme. The antibiotics comprise an eicosapentaenoic acid as an active ingredient, wherein the daily dosage of eicosapentaenoic acid is 1-2 mg/kg, preferably 0.5-1 mg/kg. A Pseudomonas sp. CJM01(KCTC 10941BP) strain having antibiotic activity against gram positive bacteria produces the eicosapentaenoic acid and is isolated from the soil. The animal feed additives or microorganism sterilizer comprises Pseudomonas sp. CJM01(KCTC 10941BP) strain or Pseudomonas sp. CJM01(KCTC 10941BP) strain cultured medium.

Abstract translation: 提供包含二十碳五烯酸作为活性成分的抗生素以抑制通常在人和动物中发生的革兰氏阳性病原菌和抗生素抗性菌株的生长，并且通过用蛋白质处理从菌株获得的二十碳五烯酸衍生物产生大量的二十碳五烯酸 分解酶。 抗生素包括二十碳五烯酸作为活性成分，其中二十碳五烯酸的日剂量为1-2mg / kg，优选0.5-1mg / kg。 假单胞菌属 对革兰氏阳性菌具有抗生素活性的CJM01（KCTC 10941BP）菌株产生二十碳五烯酸，并从土壤中分离。 动物饲料添加剂或微生物灭菌器包含假单胞菌属 CJM01（KCTC 10941BP）菌株或假单胞菌属 CJM01（KCTC 10941BP）菌株培养基。